11/22
02:11 am
cntx
Context Therapeutics (NASDAQ:CNTX) was upgraded by analysts at
Wall Stre
Low
Report
Context Therapeutics (NASDAQ:CNTX) was upgraded by analysts at
Wall Stre
11/22
02:11 am
cntx
Context Therapeutics (NASDAQ:CNTX) was upgraded by analysts at
Wall Stre
Low
Report
Context Therapeutics (NASDAQ:CNTX) was upgraded by analysts at
Wall Stre
11/7
07:30 am
cntx
Context Therapeutics Highlights CT-95 and CT-202 Programs at 2025 SITC Annual Meeting
Low
Report
Context Therapeutics Highlights CT-95 and CT-202 Programs at 2025 SITC Annual Meeting
11/6
09:39 am
cntx
Context Therapeutics GAAP EPS of -$0.10 misses by $0.01 [Seeking Alpha]
Low
Report
Context Therapeutics GAAP EPS of -$0.10 misses by $0.01 [Seeking Alpha]
11/6
08:40 am
cntx
Context Therapeutics (NASDAQ:CNTX) had its "buy" rating reaffirmed by analysts at D. Boral Capital. They now have a $9.00 price target on the stock.
Medium
Report
Context Therapeutics (NASDAQ:CNTX) had its "buy" rating reaffirmed by analysts at D. Boral Capital. They now have a $9.00 price target on the stock.
11/6
08:10 am
cntx
Context Therapeutics (NASDAQ:CNTX) had its price target raised by analysts at HC Wainwright from $4.00 to $5.00. They now have a "buy" rating on the stock.
High
Report
Context Therapeutics (NASDAQ:CNTX) had its price target raised by analysts at HC Wainwright from $4.00 to $5.00. They now have a "buy" rating on the stock.
11/5
04:15 pm
cntx
Context Therapeutics Reports Third Quarter 2025 Operating and Financial Results
Medium
Report
Context Therapeutics Reports Third Quarter 2025 Operating and Financial Results
10/28
07:30 am
cntx
Context Therapeutics to Participate in Upcoming Investor Conferences
Medium
Report
Context Therapeutics to Participate in Upcoming Investor Conferences
10/16
08:46 am
cntx
Context Therapeutics (NASDAQ:CNTX) had its "buy" rating reaffirmed by analysts at D. Boral Capital. They now have a $9.00 price target on the stock.
Medium
Report
Context Therapeutics (NASDAQ:CNTX) had its "buy" rating reaffirmed by analysts at D. Boral Capital. They now have a $9.00 price target on the stock.
10/8
07:14 am
cntx
Institutions profited after Context Therapeutics Inc.'s (NASDAQ:CNTX) market cap rose US$14m last week but private equity firms profited the most [Yahoo! Finance]
Low
Report
Institutions profited after Context Therapeutics Inc.'s (NASDAQ:CNTX) market cap rose US$14m last week but private equity firms profited the most [Yahoo! Finance]
10/6
08:06 am
cntx
Context Therapeutics Announces Poster Presentations at the Society for Immunotherapy of Cancer's (SITC) 40th Annual Meeting [Yahoo! Finance]
Medium
Report
Context Therapeutics Announces Poster Presentations at the Society for Immunotherapy of Cancer's (SITC) 40th Annual Meeting [Yahoo! Finance]
10/6
07:30 am
cntx
Context Therapeutics Announces Poster Presentations at the Society for Immunotherapy of Cancer’s (SITC) 40th Annual Meeting
Medium
Report
Context Therapeutics Announces Poster Presentations at the Society for Immunotherapy of Cancer’s (SITC) 40th Annual Meeting
10/3
04:15 pm
cntx
Context Therapeutics Announces Inducement Grant Under Nasdaq Listing Rule 5635(c)(4)
Medium
Report
Context Therapeutics Announces Inducement Grant Under Nasdaq Listing Rule 5635(c)(4)
10/2
08:02 am
cntx
Context Therapeutics (NASDAQ:CNTX) is now covered by analysts at Cantor Fitzgerald. They set an "overweight" rating on the stock.
Medium
Report
Context Therapeutics (NASDAQ:CNTX) is now covered by analysts at Cantor Fitzgerald. They set an "overweight" rating on the stock.
9/18
09:14 am
cntx
Context Therapeutics (NASDAQ:CNTX) is now covered by analysts at Guggenheim. They set a "buy" rating and a $5.00 price target on the stock.
High
Report
Context Therapeutics (NASDAQ:CNTX) is now covered by analysts at Guggenheim. They set a "buy" rating and a $5.00 price target on the stock.